resolvin-d1 and 13-hydroxy-9-11-octadecadienoic-acid

resolvin-d1 has been researched along with 13-hydroxy-9-11-octadecadienoic-acid* in 1 studies

Other Studies

1 other study(ies) available for resolvin-d1 and 13-hydroxy-9-11-octadecadienoic-acid

ArticleYear
Eicosanoids in Nonalcoholic Fatty Liver Disease (NAFLD) Progression. Do Serum Eicosanoids Profile Correspond with Liver Eicosanoids Content during NAFLD Development and Progression?
    Molecules (Basel, Switzerland), 2020, Apr-27, Volume: 25, Issue:9

    Nonalcoholic fatty liver disease (NAFLD) is becoming a major public health problem worldwide. The study aimed to evaluate the concentration of eicosanoids in serum and liver tissue during steatosis progression and to assess whether eicosanoid change scores may predict liver tissue remodeling. Thirty six eight-week-old male Sprague Dawley rats were enrolled and sacrificed at different stages of NAFLD. Eicosanoid concentrations, namely lipoxin A

    Topics: Animals; Biomarkers; Chromatography, Liquid; Dinoprostone; Disease Models, Animal; Disease Progression; Docosahexaenoic Acids; Eicosanoids; Eicosapentaenoic Acid; Hydroxyeicosatetraenoic Acids; Linoleic Acids; Lipoxins; Liver; Male; Non-alcoholic Fatty Liver Disease; Rats; Rats, Sprague-Dawley

2020